MedTrace Logo

Randomized Clinical Trial, Conventional Treatment-controlled, Studying the Efficacy of Plasma Rich in Growth Factor (PRGF®) in Alveolar Ridge Preservation After Simple Exodontia in the Anterior Region of Maxilla.

NCT04093583 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2025-02-25

No results posted yet for this study

Summary

This RCT aims to study the efficacy and safety of PRGF-Endoret in alveolar ridge preservation in the aesthetic zone. The control group is the spontaneous healing occuring after the suturing of the alveolus. The primary endpoint is the bone regeneration measured in biopsies obtained from the regenerated alveolar bone.

Conditions

  • Dental Implantation

Interventions

PROCEDURE

Exodontia

Atraumatic exodontia followed by simple suture

DRUG

Alveolar ridge preservation with a PRP (PRGF-Endoret)

Filling of the alveolus with PRGF clot and fibrin plug.

DEVICE

Preparation of PRGF using Endoret technology

Preparation of PRGF using Endoret technology following manufacturer instructions

Sponsors & Collaborators

  • Fundación Eduardo Anitua

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-07
Primary Completion
2025-01-29
Completion
2025-01-29

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04093583 on ClinicalTrials.gov